Wolverhampton CCG to Connect Pharmacies and GPs

EMISCommunity pharmacists and GPs in Wolverhampton will soon be able to offer joined up healthcare to thousands of patients, using cutting edge record-sharing technology. Wolverhampton clinical commissioning group (CCG) and EMIS Health have reached an agreement to jointly offer funding towards Pharmacy Access, a software package to enable local community pharmacies and GPs to securely share vital patient information and streamline the ordering and auditing of repeat prescriptions.

Pharmacies using the EMIS Health ProScript PMR system will be able to request repeat prescriptions electronically from GPs using the EMIS Web clinical system.

Pharmacists will also be able to view key clinical data in the GP record, including adverse reactions and allergies, historically prescribed acute and repeat medications, and test results such as the International Normalised Ratio (INR) thyroid function, blood pressure and blood sugars, amongst others. It will also facilitate advanced and enhanced services such as Medicines Use Reviews and the New Medicine Service.

The CCG is now inviting all 27 pharmacies and 35 GP practices in the area using ProScript and EMIS Web systems to roll out the technology.

The rollout will incorporate robust protocols to protect patient confidentiality. Patients must provide documented consent before the pharmacist can view their GP record. Access to the GP record within the pharmacy is governed by highly secure role-based access controls enforced by NHS Smart Cards.

Sheila Gregory, project implementation officer at Wolverhampton CCG said: "We are excited to be offering pharmacists Pharmacy Access, which shows what is possible with joined up healthcare. We look forward to measuring the clinical and administrative benefits over the next few months as the project gets up and running."

Ian Taylor, Managing Director of community pharmacy at EMIS Health said: "This is a timely project that supports the pharmacy profession's desire to play a greater role in the care of patients, through secure and relevant access to patient information.

"It will also benefit patients themselves, by better joining up their care."

Pharmacy Access is currently in place in over 150 other community pharmacies across the country.

Related news articles:

About EMIS Health
EMIS Health is part of EMIS Group plc - the UK leader in connected healthcare software and services.

EMIS Health provides software and services to clinicians working across every major UK healthcare setting, including:

  • Primary Care - market leader with 54% share of the UK GP market; its systems hold 40 million cradle to grave patient records;
  • Community Children's and Mental Health Care - 9% and growing UK market share;
  • Secondary Care - 81% of NHS Acute Trusts use an EMIS Health system; its software holds 30 million patient records in A&E alone;
  • Community Pharmacy - the single most used integrated community pharmacy and retail system (36% UK market share);
  • Specialist Care - EMIS Health is the leading provider of software and services to support diabetic eye screening (82% English market share) and other ophthalmology and specialist services.

EMIS Health is an innovator in secure data-sharing to join up healthcare. It was the first in the UK to enable community pharmacists to access information from the GP patient record - supporting safer dispensing - and the first to integrate personal health data captured on wearable consumer devices with the GP patient record.

Other businesses within EMIS Group are

  • Patient - the UK's leading provider of patient-centric medical and well-being information and related transactional services; www.patient.info attracts 18 million unique visitors a month.
  • Egton - providing specialist ICT infrastructure, software, hardware and engineering services.
  • EMIS Care - the new name for EMIS Group’s most recent acquisition, Medical Imaging, a specialist provider of grading and assessment services to support diabetic eye screening.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...